| 注册
首页|期刊导航|中国当代医药|不同肝脏疾病的肝脏血管周围晕征出现情况及其MRI表现

不同肝脏疾病的肝脏血管周围晕征出现情况及其MRI表现

汪徐 何玉麟

中国当代医药2024,Vol.31Issue(1):76-80,5.
中国当代医药2024,Vol.31Issue(1):76-80,5.

不同肝脏疾病的肝脏血管周围晕征出现情况及其MRI表现

Appearance and MRI findings of hepatic perivascular lucency in different liver diseases

汪徐 1何玉麟2

作者信息

  • 1. 江西省九江市第三人民医院影像科,江西九江 332000
  • 2. 南昌大学第一附属医院影像科,江西南昌 330006
  • 折叠

摘要

Abstract

Objective To describe the pathological mechanism and MRI findings of PVL,discuss its association with the occurrence of the same liver diseases,and evaluate the clinical significance of PVL.Methods A total of 197 patients with liver-related diseases admitted to the Third People's Hospital of Jiujiang from January 2019 to January 2020 were retro-spectively analyzed,and according to the disease type,they were divided into chronic hepatitis B group(111 cases),cirrhosis group(57 cases),and liver tumor group(29 cases).The MRI manifestations of PVL in the three groups were observed,and the MRI plain scan and enhanced image data of the upper abdomen of the patients were studied,and different liver diseases and different levels of PVL were analyzed.Results The PVL detection rate was 32.4%in patients with chronic hepatitis B,31.0%in patients with liver tumor,and 40.4%in patients with cirrhosis.The incidence of PVL in patients with cirrhosis did not change with the increase of cirrhosis grading score(P>0.05).The incidence of PVL in patients with hilar obstruction was higher than that in patients with uninvaded hilar area,and the difference was statistically significant(P<0.05).Con-clusion The MRI distribution and manifestations of PVL in different liver diseases have corresponding characteristics,which has reference value for the evaluation of the severity and prognosis of chronic hepatitis B disease,as well as the diagnosis of liver tumor invading the hepatic portal region.

关键词

肝脏血管周围晕征/慢性乙型肝炎/肝硬化/肝脏肿瘤/MRI

Key words

Liver perivascular lucency/Chronic hepatitis B/Liver cirrhosis/Liver cancer/MRI

分类

医药卫生

引用本文复制引用

汪徐,何玉麟..不同肝脏疾病的肝脏血管周围晕征出现情况及其MRI表现[J].中国当代医药,2024,31(1):76-80,5.

基金项目

江西省重点研发计划项目(20202BBGL73122). (20202BBGL73122)

中国当代医药

1674-4721

访问量0
|
下载量0
段落导航相关论文